Weaker antibody response to first COVID-19 vaccine dose found in long-term care residents

Results from a University of British Columbia study in long-term care facilities in Vancouver reveal that individuals of advanced age, following the first dose of a two-dose vaccination regimen, are less able to generate as strong an antibody response, both in terms of magnitude and function, compared to adults of younger age.